Not finding it? Sign in to also search OpenAlex live.
-
Relationship between plasma alpha-1-antitrypsin polymers and lung or liver function in ZZ alpha-1-antitrypsin deficient patients2022 01.01 - Clinical problems - no related to asthma or COPD conference-abstract Biochemistry, Genetics and Molecular Biology Protease and Inhibitor Mechanisms
Srinu Tumpara, Sabina M. Janciauskiene, Beata T. Olejnicka, Malin Fromme, Pavel Strnad, Tobias Welte, +1 more
0citations -
The effect of alpha-1 antitrypsin (AAT) augmentation therapy on the liver phenotype in individuals with homozygous Pi*Z AAT mutation (genotype Pi*ZZ)2022 05.02 - Monitoring airway disease conference-abstract Medicine Liver Disease Diagnosis and Treatment
Malin Fromme, K Hamesch, Carolin V. Schneider, M Mandorfer, K Holtz-Thorhauge, Vítor Magno Pereira, +17 more
0citations -
Final results from a prospective, multicenter, non-interventional study (BESREMi-PASS) on the safety of ropeginterferon alfa-2b in 229 patients with polycythemia vera2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Veronika Buxhofer‐Ausch, Andreas Reiter, Ciprian Tomuleasa, Albert Woelfler, Lino Lars Teichmann, Luminita Ocroteala, +7 more
0citations -
Long Term Outcomes and Renal Response Following Autologous Stem Cell Transplantation for Light Chain Deposition Disease:a Retrospective Study on Behalf of the Cmwp of the EBMT2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Laurent Garderet, Luuk A. Gras, Linda Köster, Montserrat Rovira, Laure Vincent, Guido Kobbe, +18 more
0citations -
KIF23 regulation by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma2024 Zeitschrift für Gastroenterologie conference-abstract Biochemistry, Genetics and Molecular Biology MicroRNA in disease regulation
Carolin Lohr, Rossella Pellegrino, Mihael Vucur, Veronika Büttner, Matthias Dille, Lara Rosaline Heij, +5 more
1citations -
The tetravalent death receptor 5 (DR5) agonist ozekibart (INBRX-109) in conventional chondrosarcoma (CS): Secondary efficacy endpoints from the randomized, registrational, phase 2 ChonDRAgon study.
Hans A. J. Gelderblom, Victoria E. H. Wang, Mark Doherty, Ana Sebio, Silvia Stacchiotti, Breelyn Ann Wilky, +14 more
5citations -
POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
X. Baraliakos, A. Deodhar, Désirée M F M van der Heijde, Filip E Van den Bosch, M. Magrey, Walter P. Maksymowych, +6 more
1citations
12 results